Crossmark

LncRNA ANRIL regulates AML development through modulating the glucose metabolism pathway of AdipoR1/AMPK/SIRT1

Crossref DOI link: https://doi.org/10.1186/s12943-018-0879-9

Published Online: 2018-08-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sun, Lin-Yu

Li, Xiao-Juan

Sun, Yu-Meng

Huang, Wei

Fang, Ke

Han, Cai

Chen, Zhen-Hua

Luo, Xue-Qun

Chen, Yue-Qin

Wang, Wen-Tao
Funding

Funding for this research was provided by:

National Key R&D Program of China (No. 2017YFA0504400)

National Natural Science Foundation of China (No. 81770174)

National Natural Science Foundation of China (No. 31700719)

China Postdoctoral Science Foundation (Grant No. 2017M610565)

China Postdoctoral Science Foundation (Grant No. 2017T100653)
License Information

Text and Data Mining valid from 2018-08-22
More Information

Article History

Received: 26 March 2018

Accepted: 16 August 2018

First Online: 22 August 2018

Ethics approval and consent to participate

: Patients with AML and negative controls were obtained with informed consent from the First Affiliated Hospital of Sun Yat-sen University. Sample collection was approved by the the ethics committee of the affiliated hospitals of Sun Yat-sen University.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.